Due to the neurodegenerative phenotype in MLIV disease and several studies showing TRPML1 activation to rescue lysosomal storage and neurodegenerative disease phenotypes, TRPML1 appears to be a promising novel drug target for the treatment of such diseases. The gene discussed is MCOLN1; the disease is neurodegenerative disease.